On the pharmacology of guanoxan.
D000818:Animals; D000959:Antihypertensive Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001158:Arteries; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D004285:Dogs; D004357:Drug Synergism; D004562:Electrocardiography; D004837:Epinephrine / Q000037:antagonists & inhibitors; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D006146:Guanidines / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D009541:Nictitating Membrane / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000037:antagonists & inhibitors; D010879:Piperazines / Q000037:antagonists & inhibitors; D012110:Reserpine / Q000494:pharmacology; D013566:Sympathomimetics / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014439:Tyramine / Q000037:antagonists & inhibitors
D000959:Antihypertensive Agents; D004983:Ethanolamines; D006146:Guanidines; D006584:Hexamethonium Compounds; D010879:Piperazines; D013566:Sympathomimetics; D010656:Phenylephrine; D001285:Atropine; D012110:Reserpine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine